A healthy microbiome is vital because high or low microbial diversity can have different implications for health or disease, depending on the body site. Pharma is harnessing the microbiome to potentially treat auto-immune, metabolic and infectious diseases. Pipeline microbiome therapeutics show promise, but must also overcome hurdles, as it is currently unknown how the microbiome affects human health.
Our series of Microbiome Analysis reports will help you make better and more informed decisions.
Download the guide to our Microbiome Analysis report series here.
Reports in this Series
Click through our reports below to find out more, or contact us for more information on the latest reports available.